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Attention deficit hyperactivity disorder (ADHD) is a highly prevalent neurodevelopmental
disorder characterized by a definite behavioral pattern that might lead to performance
problems in the social, educational, or work environments. In the Diagnostic and Statistical
Manual of Mental Disorders, Fifth Edition, the symptoms of ADHD were restricted to
those associated with cognitive (attention deficit) and behavioral (hyperactivity/impulsivity)
deficits, while deficient emotional self-regulation, a relevant source of morbidity, was left
out. The etiology of it is complex, as its exact causes have not yet been fully elucidated.
ADHD seems to arise from a combination of various genetic and environmental factors
that alter the developing brain, resulting in structural and functional abnormalities. The
aim of this paper was to review epigenetics and ADHD focused on how multidimensional
mechanisms influence the behavioral phenotype.
Keywords: ADHD, executive functions, emotional self-regulation, DESR, genetic factors, environmental factors,
epigenetics
Attention Deficit Hyperactivity Disorder
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized
by a definite behavioral pattern that might impair the affected individuals’ performance in the
social, educational, or work environments. According to epidemiological studies, ADHD affects
approximately 3–6% of schoolchildren worldwide and continues into adolescence and adulthood
in most cases (50–80%) (1–4). This high prevalence is a cause of concern because ADHD
has negative impacts on all neurodevelopmental areas and on the psychosocial interactions of
the affected individuals. The risk might be increased when symptoms, such as aggressiveness
and irritability, or comorbidities, such as conduct disorder or oppositional defiant disorder, are
present (5, 6).
According to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V), the
symptoms of ADHD manifest as inappropriate levels of inattention, hyperactivity, and impulsivity,
including behaviors, such as inability to pay attention to details, difficulty organizing tasks, and
activities, and restlessness or inability to remain sitting in appropriate situations (7). There is no
biological marker for ADHD. Clinical diagnosis is established according to the criteria listed in
DSM-V, based on the child’s clinical history and the repercussion of the behavioral symptoms
on their network of relationships (8). Clinical diagnosis is complemented by neuropsychological
assessment, which allows establishing the magnitude of the deficits and detecting impairments in
other functional areas.
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Neuroimaging studies indicate that ADHD is a result of
abnormal anatomical functioning and connectivity throughout
fronto-striatal, fronto-temporal, fronto-parietal, and/or fronto-
striato-parieto-cerebellar circuitry. In addition to circuitry, spe-
cific structures and areas of the brain have also received attention
and include, among others, the prefrontal cortex, anterior cin-
gulate cortex, caudate, globus pallidus, parietal regions, tempo-
ral regions, corpus callosum, splenium, cerebellar vermis, and
cerebellum (9). Neuropsychological studies combined with brain
imaging methods have detected functional alterations in neural
networks in specific brain areas related with executive functions
(EFs) (10, 11).
Executive Functions and Emotional
Self-Regulation
In recent years, studies suggested that executive dysfunction is the
main deficit in ADHD (10). The EFs are a set of cognitive skills,
associated with prefrontal cortex functions, that allow individuals
to orient and shape their behavior to attain goals (12–15). Cur-
rently, the EFs are divided into cold and hot. The cold EFs are
considered to be purely cognitive and used in tasks that require
handling abstract concepts, such as attention, working memory,
planning, cognitive flexibility, alternation, and inhibition. These
EFs aremainly relatedwith dorsolateral prefrontal cortex function
(11, 16). In turn, the hot EFs are used in tasks that demand
motivation and affect and are associatedwith the orbitofrontal and
ventromedial cortices (11, 16–18). Although neuropsychological
assessment of EFs provides a significant contribution to the under-
standing of ADHD, most tests are performed in artificial settings,
and the results often do not reflect the deficits exhibited by the
affected children in their everyday lives (19). Scales, such as the
child behavior checklist (CBCL), are currently being used to detect
behavioral deviations in the different settings of the life of a child,
such as school and home (20). In addition to provide quantitative
measures, CBCL allows for the assessment of some features of the
hot EFs, including emotional self-regulation (21).
Self-regulation might be described as an ability that allows
individuals to plan, choose between options, control impulses,
inhibit undesired thoughts, and regulate their social behavior.
These characteristics are quite close to the definition of the
hot EFs themselves. Therefore, not by chance, Barkley defined
the EFs as self-regulation. Several studies suggest that ADHD
might result fromdeficient emotional self-regulation (DESR) (22).
DESR involves deficient self-regulation of the physiological exci-
tation caused by strong emotions, difficulties inhibiting inade-
quate behaviors in response to positive or negative emotions,
problems reorienting attention after a strong emotion, and dis-
organization of coordinated behavior in response to emotional
activation. DESR traits include low tolerance to frustration, impa-
tience, irritability, and easy excitation of emotional reactions (21,
23, 24). A longitudinal study conducted with 177 children with
ADHD and 204 children without it detected strong correlations
between ADHD and DESR, which is defined as a t-score >180
but <210 on the attention, aggression, and anxiety/depression
subscales of the CBCL. Approximately 44% of the children with
ADHD exhibited a positive CBCL-DESR profile versus 2% of the
children without ADHD (21). Presence of a positive CBCL-DESR
profile was associated with higher rates of anxiety and disruptive
behavior disorders andwith greater impairments of the emotional,
interpersonal, and psychosocial functions, even after adjustment
for comorbidities (24). Those studies show that the presence of a
positive CBCL–DESR profile might help to identify the subgroup
of children with ADHD at higher risk of individual and social
impairment. As a result of deficient self-regulation, some psy-
chological processes and functions, including working memory,
internalization of expression, the sense of time, and goal-directed
behavior, do not develop in a satisfactory manner (5). From that
perspective, and thus different from the definition in the DSM-V,
attention deficit might be a secondary aspect in ADHD.
Etiology of ADHD
The etiology of ADHD has been the subject of several studies.
Although the number of such studies is large, the exact causes of
ADHD have not yet been fully elucidated. ADHD seems to result
from a combination of genetic and environmental factors that
alter the developing brain, resulting in structural and functional
abnormalities (25).
Genetic Factors
Several genetic linkage and association studies have been con-
ducted in recent years to identify candidate genes related to
ADHD (26). A recent meta-analysis that included seven linkage
studies (27–35) confirmed the importance of a region on chro-
mosome 16 (16q21–16q24). In addition, 10 genomic regions on
8 chromosomes (5, 6, 7, 8, 9, 15, 16, and 17) were associated with
ADHD (36). However, none of the studies led to the identification
of genes significantly related to ADHD but rather explained small
parts of their genetic contribution to the disease. Even association
studies of the entire genome (GWAS – genome-wide association
study) were unable to identify any significant associations and
described a rather limited superposition of genes (26).
Despite the small number of truly significant findings involving
genes, it is known that genetic factors strongly influence ADHD
(4). This phenomenon is mainly evidenced by the high heritabil-
ity, which has been estimated at 76%based on studieswith families
and adopted children (26, 36–38). Those studies confirmed that
ADHD has a genetic predisposition because the risk of disease
was higher among the biological siblings of children with ADHD
compared to the adopted ones. In addition, those studies showed
that the risk of adopted relatives of children with ADHD was
similar to that of the relatives of the children in the control group
(4, 37, 39). However, although the literature indicates that ADHD
is a highly heritable condition, no gene could yet be named as nec-
essary or sufficient for the disease to occur. Thus, the investigation
of susceptibility genes is the subject of many studies.
The main targets of such research are the genes that encode
components of the dopaminergic, noradrenergic, and serotoner-
gic systems (40–42). Dopamine is a catecholamine neurotrans-
mitter involved in the control of motion, learning, mood, emo-
tions, cognition, sleep, and memory. It is a natural precursor
of epinephrine and norepinephrine, other catecholamines with
stimulant actions on the central nervous system. Dopamine dys-
regulation is associated with several neuropsychiatric disorders,
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for which reason it was the target of many molecular studies on
ADHD (41–43). The dopamine active transporter 1 (DAT1, also
known as SLC6A3) gene was the first to be investigated, as this
transport protein is involved in the modulation of the effects
of the stimulating drugs commonly used for ADHD treatment
(44, 45). Dopamine receptors, especially DRD4 and DRD5, are
also strongly associated with ADHD development (46–48). Few
molecular studies with genes related to the noradrenergic system
have been performed. Such studies mainly focused on the gene
that encodes dopamine-beta-hydroxylase (DβH), which catalyzes
the degradation of dopamine into norepinephrine, with direct
effects on the total level of dopamine in the brain (49). The
serotonergic system might also participate in ADHD etiology,
in particular the serotonin receptor (HTR1B) and transporter
(SCL6A4) genes (50).
There is emerging evidence that GABAergic and glutamatergic
system play important roles in the pathophysiology of ADHD.
Children with ADHD appear to have more than twice the level of
glutamate, which is an excitatory neurotransmitter for neuronal
cells, and low level of gamma-aminobutyric acid (GABA), which
acts as an inhibitory molecule to inhibit stimulated neuronal cells
(51). Genetic studies have reported an association betweenADHD
and a number of glutamate receptor gene variants (GRM1, GRM5,
GRM7, and GRM8) (52). Furthermore, some animal models sug-
gest that altered glutamate regulation of the dopamine system
underpins the functional deficits associated with ADHD (53).
Some evidence points to an association between the
synaptosomal-associated protein 25 (SNAP-25) gene and ADHD.
SNAP-25 is one the proteins of the presynaptic plasma membrane
and is highly and specifically expressed in neurons, being crucial
for the fusion of synaptic vesicles and neurotransmitter release.
A study showed that rats with mutations in that gene exhibited
marked hyperactivity and other behaviors consistent with
ADHD phenotype (54). Subsequent studies have suggested that
mutations in the SNAP-25 gene might predispose individuals to
ADHD (55, 56). Monoamine oxidase A (MAO-A) participates in
the degradation of components of the dopaminergic, adrenergic,
and serotonergic systems and thus has been suggested as a
strong candidate to account for ADHD susceptibility (57).
One additional candidate is brain-derived neurotrophic factor
(BDNF), a member of the neurotrophins family, which is
involved in some neurodevelopmental processes, including the
survival and differentiation of dopaminergic neurons in the
developing brain and glutamate-dependent neuronal plasticity
in adults. Evidence gathered in animal studies shows that the
expression of BDNF increases in the amygdala, piriform cortex,
and hypothalamus of rats following repeated administration
of amphetamine, which suggests that BDNF participates in the
psychostimulant response. In addition, reduction of the central
serotonergic activity has been associated with poor impulse
regulation (a key-feature of ADHD) in youths, adults, and
animals (58).
Environmental Factors
The environmental factors that are epidemiologically associated
with ADHD include psychosocial adversities, maternal mental
disorders, violence, stress, smoking, and drinking alcohol in the
prenatal period and childhood. A longitudinal study conducted
in Brazil by Pires and colleagues sought to correlate the family
environment and pregnancy with ADHD diagnosis in children
and the symptoms described by various informants (mothers and
teachers). These authors found that family dysfunction, lack of
social support for mothers, adverse life events, and disagreements
in the course of pregnancy were associated with mother-reported
ADHD (59). ADHD is frequently associated with exposure to
violence in intrauterine life and childhood, including domestic
violence (60). Class and colleagues conducted a large population-
based study in Switzerland and found that exposure of pregnant
women to stress in the third trimester of pregnancy increased
the risk of ADHD (61). Premature birth is also associated with
increased risk of ADHD. Not only extremely (23–28weeks) but
also moderately (33–36weeks) premature birth increases the risk
of ADHD, most likely due to the degree of immaturity at birth.
Social adversities, expressed as a low maternal educational level,
also influence the risk of ADHD among children who were mod-
erately premature (62). The risk of ADHD is also higher among
children who were too small or too large for their gestational
age (63).
Exposure to tobacco smoke in the prenatal period and/or child-
hood might be highly detrimental to the child’s neurodevelop-
ment because it induces changes that alter the cell dynamics,
triggering a cascade of neurotoxic risk factors that negatively affect
sensory processing (64). Unhealthy activation of the neuronal
nicotinic acetylcholine receptors (nAChRs) through exposure to
nicotine in early childhoodmodulates the synaptic plasticity;most
likely influences endogenous cholinergic transmissions; and alters
cell, physiological, and behavioral processes in critical periods of
development (65). Studies on ADHD identified some interactions
between exposure to smoke in the prenatal period and specific
genotypic variants, particularly affecting DAT1, DRD4, and neu-
ronal acetylcholine receptor subunit alpha-4 (CHRNA4) (66–68).
For instance, children with two copies of a DAT polymorphism
exhibited greater risk of ADHD when they also had exposure to
maternal prenatal smoking (69). Children with a specific allele in
each DRD4 or DAT1 gene and a history of exposure to prenatal
smoking in a sample of 15,000 twins from the United States exhib-
ited a threefold higher risk of being diagnosed with ADHD.When
children have specific alleles in both genes, the risk is threefold
higher (67, 70).
Some evidence suggests that prenatal exposure to alcohol also
causes pathological changes that increase the risk for ADHD,
mainly resulting from the effect of alcohol on the modulation
of the expression of the catecholamine transport system. Kim
and colleagues found that prenatal exposure to ethanol in phys-
iologically significant concentrations induced hyperactive, inat-
tentive, and impulsive behavioral phenotypes in rats and their
offspring associated with increased DAT protein expression and
reduced methyl CpG-binding protein 2 (MeCP2) expression in
the prefrontal cortex and striatum (71).
Epigenetics
It is believed that the actions of the environmental factors
associated with ADHD are mediated by epigenetic mechanisms
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(72). According to the epigenetic paradigm, even structural
conditions determined by genes might be modulated, inhib-
ited, or expressed by environmental adversities or influences.
Such genomic programing directed by environmental factors is
a physiological phenomenon, a type of adaptive response that
begins as early as in intrauterine life. Understanding that social
adversities might lead to brain structural alterations are nec-
essary to detect vulnerabilities and formulate interventions at
early neurodevelopmental stages, when the brain plasticity is
greater and its modulation by means of adaptive learning is
easier.
The term “epigenetics” derives from the Greek prefix “epi”
and literally means, “above or beyond genetics.” As a whole, this
term refers to any potentially inheritable change that might alter
the expression of a gene without any direct modification of the
nucleotide sequence in the DNA. It includes transient and mod-
ifiable cell alterations, as well as stable mechanisms responsible
for the phenotypic identity of a given cell type (73–77). At the
molecular level, the epigeneticmechanisms consist in biochemical
modifications of the DNA and histone proteins – the main com-
ponents of chromatin. Additional mechanisms involving inter-
ference RNA and prions also contribute to epigenetic regulation
(78). The changes in the chromatin are countless and complex,
including methylation of DNA cytosine–guanine dinucleotides
(CpG) and post-transductional modifications of histones, includ-
ing acetylation, methylation, phosphorylation, ubiquitination,
and sumoylation. As a function of their chemical properties,
these modifications interfere with chromatin condensation and
thus modulate the access of the DNA to the transcriptional
machinery (73, 78).
In the past decade, it became increasingly clear that epige-
netic processes play crucial roles in the modulation of neu-
rodevelopment. DNA methylation patterns might be influenced
by factors, such as the quality of maternal care in the first
years of life and exposure to maltreatment in childhood, result-
ing in epigenetic markers that last for life (79). In a recent
study, Wong colleagues measured DNA methylation in promoter
regions of three genes: DRD4, the serotonin transporter gene
(SLC6A4/SERT), and the MAO-A gene. These authors analyzed
that DNA samples from 46 pairs of monozygotic twins and
45 pairs of dizygotic twins (total n= 182) aged 5–10 years old.
The results suggest that differences in DNA methylation are
apparent in early childhood, even between genetically identi-
cal individuals, and that individual differences in methylation
are not stable over time. That longitudinal study indicated that
environmental influences behave as relevant factors in the pro-
duction of individual differences in DNA methylation in the
genome (80, 81).
Epigenetic changes due to intrauterine exposure might play
critical roles in neurodevelopment, and maternal smoking is
a significant risk factor for various adverse health outcomes
in children. Joubert and colleagues investigated epigenome-
wide methylation in 1062 samples of cord blood from new-
borns in relation to maternal smoking during pregnancy. These
authors identified a set of genes with methylation changes at
birth in children whose mothers smoked during pregnancy.
That set included the AHRR and CYP1A1 genes, which are
known to participate in the detoxification of the compo-
nents of tobacco smoke through the aromatic hydrocarbon
receptor signaling pathway, and gene GHI1, which had not
been previously associated with the response to exposure to
tobacco smoke but participates in fundamental developmental
processes (82).
It is believed that the effects of the environmental factors
associated with behavioral phenotypes, such as ADHD, are
mediated by epigenetic changes in specific neuronal sites (72).
In 2014, van Mil and colleagues sought to establish whether
the methylation patterns of neuronal genes observed at birth
were associated with the occurrence of ADHD symptoms at
age 6 years old. Patterns of DNA methylation were assessed
in cord blood samples to prospectively investigate their asso-
ciations with ADHD. Global analysis of 11 genomic regions
showed that lower DNA methylation levels were associated with
higher ADHD symptom scores. However, the authors could
not distinguish whether genetic, non-genetic intragenerational
transmission, or unknown environmental factors underlay that
association (83).
Future Prospects
The studies associating epigenetics and ADHD are still in
their early stages, and new research lines with multidimen-
sional scope are needed to understand how epigenetic mecha-
nisms intervene in the determination of behavioral phenotypes.
Early life experiences, involving primary affective-regulatory
processes, may become embedded in the circuitry of the
developing brain through epigenetic modifications and lead
to long-term changes in neurobiology and behavior. Analy-
sis of the full genome using high-resolution methylation array
(like Infinium HumanMethylation450 BeadChip array – Illu-
mina) allows for the identification of the methylation pattern
that underlies clinical phenotypic variations. Wide association
of the epigenome and changes in the methylation profile
might be used in the investigation of patients exhibiting symp-
toms regarding deficits in self-regulation and behavioral dis-
orders, such as ADHD. The ability to screen the genome
for high-resolution opens a new perspective for neurophysio-
logical diagnosis, contributes to elucidation of the roles that
epigenetic mechanisms play in the susceptibility to various
emotional clinical phenotypes and might contribute to the for-
mulation of positive behavioral interventions targeting indi-
viduals with ADHD, in addition to grounding appropriate
treatments.
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